Major shareholder of Rohto Pharmaceutical Co.,Ltd.
Other assets (est.): the sum of each year's after-tax income (pay + dividends in own name − estimated taxes and social insurance) and dividends retained by asset-management companies (less about 20% corporate tax), for the years we have data. Spending, real estate, donations and savings from earlier years are not reflected.
| Company | Held by | Shares | Stake | Price | Value | Dividends |
|---|---|---|---|---|---|---|
| Rohto Pharmaceutical Co.,Ltd. 4527 · FY ending Mar 2026 |
Own name | 3,623,000 | 1.60% | ¥2,410 | ¥8.7B | ¥167M |